• Explore /
  • Poster
  • / An investigator-initiated trial to evaluate safety and tolerability of YSCH-01 in patients with recurrent glioblastoma.

An investigator-initiated trial to evaluate safety and tolerability of YSCH-01 in patients with recurrent glioblastoma.

Abstract Poster

Authors

null

Hafiz Khuram Raza

Shanghai Yuansong Biotechnology Co., Ltd., Shanghai, China

Hafiz Khuram Raza , Kang-jian Zhang , Zanyi Wu , Xian-long Fang , Xue-ping Cao , Shan Jiang , Zhi-feng Shi , Yanqiu Liu , Ruimei Li , De-zhi Kang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Immuno-therapies

Clinical Trial Registration Number

NCT05914935

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr TPS33)

DOI

10.1200/JCO.2024.42.23_suppl.TPS33

Abstract #

TPS33

Poster Bd #

L5

Abstract Disclosures

Similar Posters

First Author: Michael Lim

First Author: Damien Pouessel

First Author: Kevin J. Harrington

First Author: Andrew E. Sloan